dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorIrmandade da Santa Casa de Misericórdia de São Paulo
dc.date.accessioned2019-10-06T16:48:48Z
dc.date.accessioned2022-12-19T18:57:48Z
dc.date.available2019-10-06T16:48:48Z
dc.date.available2022-12-19T18:57:48Z
dc.date.created2019-10-06T16:48:48Z
dc.date.issued2019-01-18
dc.identifierAdvances in rheumatology (London, England), v. 59, n. 1, p. 3-, 2019.
dc.identifier2523-3106
dc.identifierhttp://hdl.handle.net/11449/189684
dc.identifier10.1186/s42358-019-0049-9
dc.identifierS2523-31062019000100201
dc.identifier2-s2.0-85060161443
dc.identifierS2523-31062019000100201.pdf
dc.identifier7098310008371632
dc.identifier0000-0002-7631-7093
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5370722
dc.description.abstractOBJECTIVE: To evaluate prevalence, clinical manifestations, laboratory abnormalities, treatment and outcome in a multicenter cohort of childhood-onset systemic lupus erythematosus (cSLE) patients with and without panniculitis. METHODS: Panniculitis was diagnosed due to painful subcutaneous nodules and/or plaques in deep dermis/subcutaneous tissues and lobular/mixed panniculitis with lymphocytic lobular inflammatory infiltrate in skin biopsy. Statistical analysis was performed using Bonferroni correction(p < 0.004). RESULTS: Panniculitis was observed in 6/847(0.7%) cSLE. Painful subcutaneous erythematosus and indurated nodules were observed in 6/6 panniculitis patients and painful subcutaneous plaques in 4/6. Generalized distribution was evidenced in 3/6 and localized in upper limbs in 2/6 and face in 1/6. Cutaneous hyperpigmentation and/or cutaneous atrophy occurred in 5/6. Histopathology features showed lobular panniculitis without vasculitis in 5/6(one of them had concomitant obliterative vasculopathy due to antiphospholipid syndrome) and panniculitis with vasculitis in 1/6. Comparison between cSLE with panniculitis and 60 cSLE without panniculitis with same disease duration [2.75(0-11.4) vs. 2.83(0-11.8) years,p = 0.297], showed higher frequencies of constitutional involvement (67% vs. 10%,p = 0.003) and leukopenia (67% vs. 7%,p = 0.002). Cutaneous atrophy and hyperpigmentation occurred in 83% of patients. CONCLUSIONS: Panniculitis is a rare skin manifestation of cSLE occurring in the first three years of disease with considerable sequelae. The majority of patients have concomitant mild lupus manifestations.
dc.languageeng
dc.relationAdvances in rheumatology (London, England)
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectChildhood
dc.subjectLupus erythematosus panniculits
dc.subjectSystemic lupus erythematosus and multicenter study
dc.titlePanniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución